Biotechnology - Schlieren, Zurich, Switzerland
The preclinical biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting